US4198510A - Piperidenylmethylidene phosphonylamidines - Google Patents
Piperidenylmethylidene phosphonylamidines Download PDFInfo
- Publication number
- US4198510A US4198510A US05/922,524 US92252478A US4198510A US 4198510 A US4198510 A US 4198510A US 92252478 A US92252478 A US 92252478A US 4198510 A US4198510 A US 4198510A
- Authority
- US
- United States
- Prior art keywords
- preparation
- subjected
- mixture
- yield
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 37
- -1 alkyl radical Chemical class 0.000 claims abstract description 25
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 7
- 239000004305 biphenyl Substances 0.000 claims abstract description 7
- 235000010290 biphenyl Nutrition 0.000 claims abstract description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 5
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 2
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims description 2
- 229910052736 halogen Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 150000002367 halogens Chemical group 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 44
- 238000000034 method Methods 0.000 abstract description 35
- 150000002081 enamines Chemical class 0.000 abstract description 24
- 150000001735 carboxylic acids Chemical class 0.000 abstract description 8
- 239000000543 intermediate Substances 0.000 abstract description 5
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 abstract description 2
- 125000005936 piperidyl group Chemical group 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 101100386054 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CYS3 gene Proteins 0.000 abstract 1
- 101150035983 str1 gene Proteins 0.000 abstract 1
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 54
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
- 239000000203 mixture Substances 0.000 description 39
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 36
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 30
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 30
- 239000011541 reaction mixture Substances 0.000 description 30
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 28
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 27
- 150000001409 amidines Chemical class 0.000 description 27
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 26
- 239000002904 solvent Substances 0.000 description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 22
- 238000010626 work up procedure Methods 0.000 description 21
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 19
- 238000004821 distillation Methods 0.000 description 17
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 16
- 238000002844 melting Methods 0.000 description 16
- 230000008018 melting Effects 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- 239000012300 argon atmosphere Substances 0.000 description 15
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 15
- 150000002576 ketones Chemical class 0.000 description 14
- 239000012024 dehydrating agents Substances 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 239000002808 molecular sieve Substances 0.000 description 12
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 11
- 239000012043 crude product Substances 0.000 description 10
- 238000000921 elemental analysis Methods 0.000 description 10
- 238000002329 infrared spectrum Methods 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000000704 physical effect Effects 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- NTPLXRHDUXRPNE-UHFFFAOYSA-N 4-methoxyacetophenone Chemical compound COC1=CC=C(C(C)=O)C=C1 NTPLXRHDUXRPNE-UHFFFAOYSA-N 0.000 description 4
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N propiophenone Chemical compound CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- FFSAXUULYPJSKH-UHFFFAOYSA-N butyrophenone Chemical compound CCCC(=O)C1=CC=CC=C1 FFSAXUULYPJSKH-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- QEFARIGNOOOMDW-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-(6-methoxynaphthalen-2-yl)-1-pyrrolidin-1-ylpropan-1-imine Chemical compound C1=CC2=CC(OC)=CC=C2C=C1C(C)C(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 QEFARIGNOOOMDW-UHFFFAOYSA-N 0.000 description 2
- HRRMRIJLNRYYLD-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-phenyl-1-pyrrolidin-1-ylbutan-1-imine Chemical compound C=1C=CC=CC=1C(CC)C(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 HRRMRIJLNRYYLD-UHFFFAOYSA-N 0.000 description 2
- PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- HXSQHQTXXONKGV-UHFFFAOYSA-N 1-(1-dibenzofuran-2-ylprop-1-enyl)pyrrolidine Chemical compound C=1C=C2OC3=CC=CC=C3C2=CC=1C(=CC)N1CCCC1 HXSQHQTXXONKGV-UHFFFAOYSA-N 0.000 description 1
- GLNVZYIDKFKFBT-UHFFFAOYSA-N 1-(1-phenylbut-1-enyl)pyrrolidine Chemical compound C=1C=CC=CC=1C(=CCC)N1CCCC1 GLNVZYIDKFKFBT-UHFFFAOYSA-N 0.000 description 1
- SZRLMHFEVOKFOM-UHFFFAOYSA-N 1-(1-phenylpenta-1,4-dienyl)pyrrolidine Chemical compound C=1C=CC=CC=1C(=CCC=C)N1CCCC1 SZRLMHFEVOKFOM-UHFFFAOYSA-N 0.000 description 1
- LRYVEAFFROBTKD-UHFFFAOYSA-N 1-(1-phenylprop-1-enyl)piperidine Chemical compound C=1C=CC=CC=1C(=CC)N1CCCCC1 LRYVEAFFROBTKD-UHFFFAOYSA-N 0.000 description 1
- AYPYUJHNTFESIM-UHFFFAOYSA-N 1-(1-phenylprop-1-enyl)pyrrolidine Chemical compound C=1C=CC=CC=1C(=CC)N1CCCC1 AYPYUJHNTFESIM-UHFFFAOYSA-N 0.000 description 1
- AXUPTKHKSZGEMN-UHFFFAOYSA-N 1-[1-(6-methoxynaphthalen-2-yl)prop-1-enyl]pyrrolidine Chemical compound C1=CC2=CC(OC)=CC=C2C=C1C(=CC)N1CCCC1 AXUPTKHKSZGEMN-UHFFFAOYSA-N 0.000 description 1
- HFTCBIZFXPDUHF-UHFFFAOYSA-N 1-[1-[4-(2-methylpropyl)phenyl]prop-1-enyl]pyrrolidine Chemical compound C=1C=C(CC(C)C)C=CC=1C(=CC)N1CCCC1 HFTCBIZFXPDUHF-UHFFFAOYSA-N 0.000 description 1
- KYGSYTRHCDNSGS-UHFFFAOYSA-N 1-phenylpent-4-en-1-one Chemical compound C=CCCC(=O)C1=CC=CC=C1 KYGSYTRHCDNSGS-UHFFFAOYSA-N 0.000 description 1
- NAGQTONWOYGDOB-UHFFFAOYSA-N 2-(2-prop-2-enylphenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC=C1CC=C NAGQTONWOYGDOB-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N 2-(6-methoxy-2-naphthalenyl)propanoic acid Chemical compound C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- BLBHILMOTNYXHE-UHFFFAOYSA-N 2-dibenzofuran-1-yl-n-diphenoxyphosphoryl-1-pyrrolidin-1-ylpropan-1-imine Chemical compound C=1C=CC=2OC3=CC=CC=C3C=2C=1C(C)C(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 BLBHILMOTNYXHE-UHFFFAOYSA-N 0.000 description 1
- SJZYLHAGVNSSLO-UHFFFAOYSA-N 2-dibenzofuran-2-ylpropanoic acid Chemical compound C1=CC=C2C3=CC(C(C(O)=O)C)=CC=C3OC2=C1 SJZYLHAGVNSSLO-UHFFFAOYSA-N 0.000 description 1
- YRNDGUSDBCARGC-UHFFFAOYSA-N 2-methoxyacetophenone Chemical compound COCC(=O)C1=CC=CC=C1 YRNDGUSDBCARGC-UHFFFAOYSA-N 0.000 description 1
- YYEROYLAYAVZNW-UHFFFAOYSA-N 2-methyl-2-phenylpropanoic acid Chemical compound OC(=O)C(C)(C)C1=CC=CC=C1 YYEROYLAYAVZNW-UHFFFAOYSA-N 0.000 description 1
- OFJWFSNDPCAWDK-UHFFFAOYSA-N 2-phenylbutyric acid Chemical compound CCC(C(O)=O)C1=CC=CC=C1 OFJWFSNDPCAWDK-UHFFFAOYSA-N 0.000 description 1
- 101100177155 Arabidopsis thaliana HAC1 gene Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 239000003810 Jones reagent Substances 0.000 description 1
- 101100434170 Oryza sativa subsp. japonica ACR2.1 gene Proteins 0.000 description 1
- 101100434171 Oryza sativa subsp. japonica ACR2.2 gene Proteins 0.000 description 1
- 101150108015 STR6 gene Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- LNYDVEQYTXBYIJ-UHFFFAOYSA-N [3-(1-diphenoxyphosphorylimino-1-pyrrolidin-1-ylpropan-2-yl)phenyl]-phenylmethanone Chemical compound C=1C=CC(C(=O)C=2C=CC=CC=2)=CC=1C(C)C(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 LNYDVEQYTXBYIJ-UHFFFAOYSA-N 0.000 description 1
- VXDSLUMUNWTSDB-UHFFFAOYSA-N acetic acid;chloroform;methanol Chemical compound OC.CC(O)=O.ClC(Cl)Cl VXDSLUMUNWTSDB-UHFFFAOYSA-N 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000410 anti-febrile effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- KXUHSQYYJYAXGZ-UHFFFAOYSA-N isobutylbenzene Chemical compound CC(C)CC1=CC=CC=C1 KXUHSQYYJYAXGZ-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- SCAMPQMOTMZWDO-UHFFFAOYSA-N n-diphenoxyphosphoryl-1-morpholin-4-yl-2-phenylpropan-1-imine Chemical compound C=1C=CC=CC=1C(C)C(N1CCOCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 SCAMPQMOTMZWDO-UHFFFAOYSA-N 0.000 description 1
- ZJDCNEBUPFJARI-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-(4-methoxyphenyl)-1-pyrrolidin-1-ylethanimine Chemical compound C1=CC(OC)=CC=C1CC(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 ZJDCNEBUPFJARI-UHFFFAOYSA-N 0.000 description 1
- YJMNNXRBLWLUKI-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-[4-(2-methylpropyl)phenyl]-1-pyrrolidin-1-ylpropan-1-imine Chemical compound C1=CC(CC(C)C)=CC=C1C(C)C(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 YJMNNXRBLWLUKI-UHFFFAOYSA-N 0.000 description 1
- STWKMFWZQBMWSO-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-phenyl-1-piperidin-1-ylpropan-1-imine Chemical compound C=1C=CC=CC=1C(C)C(N1CCCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 STWKMFWZQBMWSO-UHFFFAOYSA-N 0.000 description 1
- JUIAPMUIKURJEY-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-phenyl-1-pyrrolidin-1-ylethanimine Chemical compound C=1C=CC=CC=1OP(N=C(CC=1C=CC=CC=1)N1CCCC1)(=O)OC1=CC=CC=C1 JUIAPMUIKURJEY-UHFFFAOYSA-N 0.000 description 1
- LAOWGZGWOWEOTN-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-phenyl-1-pyrrolidin-1-ylpent-4-en-1-imine Chemical compound C=1C=CC=CC=1C(CC=C)C(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 LAOWGZGWOWEOTN-UHFFFAOYSA-N 0.000 description 1
- DGBUOYPLHBLIOO-UHFFFAOYSA-N n-diphenoxyphosphoryl-2-phenyl-1-pyrrolidin-1-ylpropan-1-imine Chemical compound C=1C=CC=CC=1C(C)C(N1CCCC1)=NP(=O)(OC=1C=CC=CC=1)OC1=CC=CC=C1 DGBUOYPLHBLIOO-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- WXDDGOHMUKLOKV-UHFFFAOYSA-N phenyl-[3-(1-pyrrolidin-1-ylprop-1-enyl)phenyl]methanone Chemical compound C=1C=CC(C(=O)C=2C=CC=CC=2)=CC=1C(=CC)N1CCCC1 WXDDGOHMUKLOKV-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/91—Dibenzofurans; Hydrogenated dibenzofurans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
Definitions
- the present invention relates to a process for the preparation of carboxylic acids and intermediates therefor as well as the intermediates themselves and more particularly to novel enamine and amidine compounds and process for the preparation of the novel compounds as well as novel process for the preparation of known carboxylic acid derivatives through said novel compounds.
- R 1 represents hydrogen atom or lower alkyl radical
- R 2 represents hydrogen atom, lower alkyl or allyl radical
- R 3 represents phenyl, lower alkyl substituted phenyl, lower alkoxy substituted phenyl, cyclohexenyl substituted phenyl, benzoyl substituted phenyl, alkoxy substituted naphthyl, dibenzofuranyl, or halogen substituted biphenyl radical.
- aromatic radical substituted carboxylic acids inclusive of the compounds (I) have antiphlogistic, analgesic, antifebrile actions and an action for preventing coagulation of blood (thrombus) and thus are usable as pharmaceutical agents (Jap. Pat. Publn. Nos. 7 491/1965, 22 297/1968, 18 105/1972 and others).
- a principal object of the present invention is to provide a novel process for the preparation of such carboxylic acids, which are reduced in number of process steps.
- Another object of the present invention is to provide novel intermediates for preparing the carboxylic acids.
- a still other object of the present invention is to provide a process for the preparation of such novel intermediates.
- the compounds (I) are prepared by subjecting a ketone represented by a formula
- R 3 represents the meanings as referred to and R 5 represents a lower alkyl or vinyl ethyl radical, to react with a secondary amine represented by a formula
- R 4 represents dimethylamino, pyrrolidyl, piperidyl or morpholyl radical, in an inert solvent and in the presence of a dehydrating agent, subjecting the resulting enamine compound represented by a formula ##STR4## wherein R 1 , R 2 , R 3 and R 4 represents the meanings as referred to, to react with Diphenyl Phosphorazidate (hereinafter referred merely to DPPA), and then hydrolyzing the resulting amidine compounds represented by a formula ##STR5## wherein R 1 , R 2 , R 3 and R 4 represent the meanings as referred to.
- DPPA Diphenyl Phosphorazidate
- benzene or toluene can be employed as the solvent and the amidine compounds (V) may be synthesized without isolating the corresponding enamine compounds.
- the enamine compounds would be isolated from the reaction mixture, ethyl acetate, tetrahydrofran, cyclohexane, N,N-dimethylformamide, N,N-dimethylsulfoxide or the like solvent may be employed in the synthesis of the amidine compounds, in addition to said solvents of benzene and toluene. It is preferable to use ethylene glycol as the solvent, when the amidine compounds are hydrolyzed.
- the melting point of 2,4-dinitrophenylhydrazone of this compound was 170°-171.5° C.
- the crude product was recrystalized from ethyl acetate-hexane to obtain colorless crystals having melting point of 67° to 69° C.
- the crude product was recrystalized from ethyl acetate-hexane to obtain colorless prisms having melting point of 71° to 73.5° C.
- the crude product was recrystalized from ethyl acetate-hexane to obtain colorless needles having melting point of 102.5° to 105° C.
- Example 25 The process was similar to that as described in Example 25 except that the reaction was carried out under argon atmosphere to obtain 1.84 g of the desired amidine (yield: 82%).
- the product had physical properties as described in Example 25.
- Boiling point 103° to 105° C./3 mmHg
- the crude product was purified by a silica-gel chromatography with chloroform-methanol-acetic acid (200:10:1) to obtain 157 mg of colorless needle crystals (yield: 71%).
- the reaction mixture was subjected to the work up as described in Example 37 to obtain 139 mg of the crude acid.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A process for the preparation of carboxylic acids represented by a formula ##STR1## wherein R1 represents hydrogen atom or a lower alkyl radical, R2 represents hydrogen atom, lower alkyl or allyl radical and R3 represents phenyl, substituted phenyl, substituted naphthyl, dibenzofuranyl or substituted biphenyl. Following novel enamine and amidine compounds as intermediates for manufacturing the carboxylic acids and processes for the manufacture of said enamine and amidine compounds ##STR2## wherein R1, R2 and R3 represent the meanings as referred to and R4 represents dimethylamino, pyrrolidyl, piperidyl or morpholyl.
Description
The present invention relates to a process for the preparation of carboxylic acids and intermediates therefor as well as the intermediates themselves and more particularly to novel enamine and amidine compounds and process for the preparation of the novel compounds as well as novel process for the preparation of known carboxylic acid derivatives through said novel compounds.
The final product of carboxylic acids are shown by the formula ##STR3## wherein R1 represents hydrogen atom or lower alkyl radical, R2 represents hydrogen atom, lower alkyl or allyl radical and R3 represents phenyl, lower alkyl substituted phenyl, lower alkoxy substituted phenyl, cyclohexenyl substituted phenyl, benzoyl substituted phenyl, alkoxy substituted naphthyl, dibenzofuranyl, or halogen substituted biphenyl radical.
It has been well known that aromatic radical substituted carboxylic acids inclusive of the compounds (I) have antiphlogistic, analgesic, antifebrile actions and an action for preventing coagulation of blood (thrombus) and thus are usable as pharmaceutical agents (Jap. Pat. Publn. Nos. 7 491/1965, 22 297/1968, 18 105/1972 and others).
Hitherto, however, such aromatic radical substituted carboxylic acids have generally been prepared through 5 to 7 steps. This means it is not so preferable for the preparation thereof in industrial scale.
Therefore, a principal object of the present invention is to provide a novel process for the preparation of such carboxylic acids, which are reduced in number of process steps.
Another object of the present invention is to provide novel intermediates for preparing the carboxylic acids.
A still other object of the present invention is to provide a process for the preparation of such novel intermediates.
According to the present invention, the compounds (I) are prepared by subjecting a ketone represented by a formula
R.sub.3 --CO--R.sub.5 (II)
wherein R3 represents the meanings as referred to and R5 represents a lower alkyl or vinyl ethyl radical, to react with a secondary amine represented by a formula
R.sub.4 H (III)
wherein R4 represents dimethylamino, pyrrolidyl, piperidyl or morpholyl radical, in an inert solvent and in the presence of a dehydrating agent, subjecting the resulting enamine compound represented by a formula ##STR4## wherein R1, R2, R3 and R4 represents the meanings as referred to, to react with Diphenyl Phosphorazidate (hereinafter referred merely to DPPA), and then hydrolyzing the resulting amidine compounds represented by a formula ##STR5## wherein R1, R2, R3 and R4 represent the meanings as referred to.
Almost all ketones as the raw material are commercially sold and easily available from markets but if necessary can be synthesized by utilizing Friedel-Crafts reaction [C. Friedel and J. M. Crafts "Compt. Rond" Vol. 84, pages 1392 and 1450 (1877)] or the like, as shown in the following formulae. ##STR6## wherein R3 and R5 represent the meaning as referred to.
For synthesizing the enamine compounds (IV), benzene or toluene can be employed as the solvent and the amidine compounds (V) may be synthesized without isolating the corresponding enamine compounds. When it is desired that the enamine compounds would be isolated from the reaction mixture, ethyl acetate, tetrahydrofran, cyclohexane, N,N-dimethylformamide, N,N-dimethylsulfoxide or the like solvent may be employed in the synthesis of the amidine compounds, in addition to said solvents of benzene and toluene. It is preferable to use ethylene glycol as the solvent, when the amidine compounds are hydrolyzed.
The present invention will now be further explained with reference to Examples.
In 50 ml of benzene, 9.38 g of propiophenone, 14.93 g of pyrrolidine and 0.99 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 67 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent under a reduced pressure, the residue was subjected to a distillation under a reduced pressure to obtain 10.33 g of the desired enamine (yield: 79%).
b.p. 101° C./3 mmHg.
In 50 ml of toluene, 4.44 g of n-butyrophenone, 6.40 g of pyrrolidine and 0.43 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 47 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent under a reduced pressure, the residue was subjected to a distillation under a reduced pressure to obtain the desired enamine as a pale yellowish oil (yield: 4.66 g, 77%).
b.p. 106° to 108° C./4 mmHg
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR9##
______________________________________ a) 0.88 (3H, t, J = 7.2Hz) b) -1.78 (6H, m) c) 2.81 (4H, m) d) 4.23 (1H, t, J = 7.2Hz) e) 7.19 (5H, s) ______________________________________
In 50 ml of toluene, 1.60 g of 4-pentenophenone, 2.13 g of pyrrolidine and 0.14 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 46 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent under a reduced pressure, the residue was subjected to a distillation under a reduced pressure to obtain 1.68 g of the desired enamine (yield: 79%).
b.p. 80° to 84° C./0.15 mmHg
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR11##
______________________________________
a) 1.8 (4H, m)
b) 2.53 t and t
(6H, )
c) 2.8 m
d) 4.20 (1H, t, J=7.8Hz)
e) 4.99-4.69 (2H, m)
f) 6.02-5.39 (1H, m)
g) 7.19 (5H, s)
______________________________________
In 30 ml of toluene, 2.68 g of propiophenone, 5.30 g of piperidine and 0.14 g of boron trifluoride etherate were dissolved. The mixture was treated in a manner similar to Example 1 to obtain 2.50 g of the desired enamine (yield: 50%).
b.p. 99.5° to 100° C./3 mmHg
In 30 ml of toluene, 5.36 g of propiophenone, 0.45 g of morpholine and 0.28 g of boron trifluoride etherate were dissolved. The mixture was treated in a manner similar to Example 1 to obtain 4.46 g of the desired enamine (yield: 50.9%).
b.p. 103° C./3 mmHg
In 30 ml of toluene, 0.751 g of 4-methoxy acetophenone, 1.07 g of pyrrolidine and 0.03 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 18 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent, the residue was subjected to a distillation under a reduced pressure to obtain 0.202 g of the desired enamine (yield: 20%).
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR15##
______________________________________
a) 1.84 m )
(4H,
b) 2.91 m
c) 4.7 s )
(4H,
d) 4.71 s
e) 7.15-6.52 (4H, m)
cap
IR spectrum: ν cm.sup.-1
max
______________________________________
IR spectrum: νmax cap cm-1
1605, 1510, 1370, 1245, 1170, 1035 and 830
In 40 ml of dried benzene, 3.80 g of 4-isobutylpropiophenone, 4.27 g of pyrrolidine and 0.28 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 50 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent under a reduced pressure, the residue was subjected to a distillation under a reduced pressure to obtain 3.84 g of the desired enamine (yield: 79%).
b.p. 112° to 114° C./0.4 mmHg
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR17##
______________________________________ a) 0.90 (6H, d, J=6Hz) b) 1.43 (3H, d, J=7.2Hz) c) -1.7 (5H, m) d) 2.43 (2H, d, J=7.2Hz) e) -2.8 (4H, m) f) 4.26 (1H, q, J=7.2Hz) g) 7.05 (4H, s) ______________________________________
The starting ketone was prepared in the following manner. ##STR18##
10.56 g of aluminum chloride was added in 36 ml of methylene chloride. To the resulting mixture, 7.77 g of propionylchloride was added drop-wise with stirring and ice cooling within 20 minutes. To the resulting mixture, 8.04 g of isobutylbenzene was added in drop-wise within 1 hour and then the mixture was stirred for 2 hours at room temperature and then kept to stand over night. The reaction mixture was poured into a mixture of 120 g of ice and 17 ml of conc. hydrochloric acid to obtain methylene chloride layer and then the water layer was extracted with chloroform. The both extracts were combined together, washed subsequently with water, 2% aqueous solution of sodium hydroxide and water, and dried on sodium sulfate. After having distilled out the solvent under a reduced pressure, the residue was subjected to a distillation under a reduced pressure to obtain the desired ketone (yield: 87%).
b.p. 86°-87° C./0.3 mmHg
The melting point of 2,4-dinitrophenylhydrazone of this compound was 170°-171.5° C.
Elemental Analysis: C19 H22 N4 O4 Cal. C: 61.61; H: 5.99; N: 15.13; Found C: 61.72; H: 6.03; N: 14.85.
In 60 ml of toluene, 1.67 g of the starting ketone, 1.49 g of pyrrolidine and 0.10 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 25 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent, the residue was subjected to a distillation under a reduced pressure to obtain 0.83 g of the desired enamine (yield: 41%).
b.p. 160° to 162° C./0.11 mmHg
NMR spectrum: δ ppm, CDCl3
______________________________________ ##STR20##
______________________________________
(a) 1.55 d, J = 7.2Hz
(7H,
(b) 1.78 m
(c) 2.84 (4H, m)
(d) 4.47 (1H, q, J = 7.2Hz)
(e) 7.87-7.42 (9H, m)
______________________________________
In 50 ml of toluene, 1.14 g of the starting ketone, 1.07 g of pyrrolidine and 0.07 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 38 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent, a small amount of dried toluene was added to the residue and then ice-cooled. After having filtered to remove crystals, the filtrate was distilled to distill out the solvent under a reduced pressure and then the residue was subjected to a distillation under a reduced pressure to obtain 579 mg of the desired enamine (yield: 33%).
b.p. 136° to 138° C./3 mmHg
NMR spectrum: δ ppm, CDCl3
______________________________________ ##STR22##
______________________________________
(a) 1.54 d, J = 6.6Hz
(7H )
(b) 1.77 m
(c) 2.83 (4H, m)
(d) 4.44 (1H, q, J = 6.6Hz)
(e) 7.41-6.97 (8H, m)
______________________________________
In 50 ml of benzene, 6.43 g of the starting ketone, 6.40 g of pyrrolidine and 0.43 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 68 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent, the residue was subjected to a distillation under a reduced pressure to obtain 5.25 g of the desired enamine (yield: 65%).
b.p. 148° to 152° C./0.2 mmHg
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR24##
______________________________________
(a) 1.52 d, J = 7.2Hz
(7H, )
(b) 1.79 m
(c) 2.79 (4H, m)
(d) 3.84 (3H, s)
(e) 4.35 (1H, q, J = 7.2Hz)
(f) 7.63-6.96 (6H, m)
______________________________________
In 100 ml of toluene, 2 g of the starting ketone, 2.12 g of pyrrolidine and 0.14 g of boron trifluoride etherate were dissolved. The mixture was refluxed for 47 hours under argon atmosphere using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent, the residue was subjected to a distillation under a reduced pressure to obtain 0.95 g of the desired enamine (yield: 34%).
b.p. 168° to 170° C./0.45 mmHg
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR26##
______________________________________
(a) 1.51 d, J = 7.2Hz
(7H, )
(b) 1.75 m
(c) 2.83 (4H, m)
(d) 4.37 (1H, q, J = 7.2Hz)
(e) 7.93-7.16 (7H, m)
______________________________________
1.01 g of enamine prepared by the process as described in Example 1 was dissolved in 15 ml of ethyl acetate and to the resulting mixture, there was added in drop-wise 1.65 g of DPPA. The mixture was stirred for 1 hour at room temperature, heated at 40° C. to cause a reaction for 1 hour and then refluxed for 2 hours. To the resulting reaction solution, 100 ml of a mixture of ethyl acetate and benzene (1/1) was added and subsequently washed with each 30 ml of 5% citric acid solution, water, saturated sodium chloride solution, saturated sodium bicarbonate solution, water and saturated sodium chloride solution, dried on anhydrous magnesium sulfate and then distilled out the solvent under a reduced pressure. The residue was subjected to a silica-gel column chromatography with a mixture of benzene-ethyl acetate (1/5) to obtain 1.91 g of the crude phosphoryl amidine (yield: 81%). The crude compound was recrystallized from ethyl acetate-hexane to obtain colorless needles having melting point of 74° to 76° C.
Elemental Analysis (C25 H27 N2 O3 P):
Cal. C: 69.11; H: 6.26; N: 6.45; Found C: 68.72; H: 6.53; N: 6.47.
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR28##
______________________________________
(a) 1.47 d, J = 7Hz
(7H, )
(b) 1.61 m
(c) 3.41-2.13 (4H, m)
(d) 4.79 (1H, q, J = 7Hz)
(e) 7.11 (15H)
______________________________________
A process similar to that as described in Example 12, excepting that tetrahydrofuran was employed in lieu of ethyl acetate, to obtain the desired compound at yield of 80%. Physical properties of the product were same with those of the compound obtained by the process as described in Example 12.
670 mg of propiophenone, 1.07 g of pyrrolidine and 0.07 g of boron trifluoride etherate were dissolved in 30 ml of toluene. The mixture was refluxed for 40 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. After having distilled out the solvent under a reduced pressure, 1.65 g of DPPA and 15 ml of tetrahydrofuran were added to the residue and the resulting mixture was stirred for 24 hours at room temperature and under argon atmosphere. Thereafter, the reaction mixture were subjected to the work up as described in Example 12 to obtain 1.83 g of the desired amidine (yield from ketone: 84%). Physical properties of the product were same with those of the compound obtained by the process as described in Example 12.
1.09 g of enamine prepared by the process as described in Example 4 and 1.65 g of DPPA were dissolved in 15 ml of ethyl acetate. The mixture was stirred for 75 minutes at room temperature, 30 minutes at 50° C. and 30 minutes at 80° C. and then refluxed for 3 hours. The reaction mixture was subjected to the work up as described in Example 12 to obtain 1.61 g of the desired amidine (yield: 67%).
The crude product was recrystalized from ethyl acetate-hexane to obtain colorless crystals having melting point of 67° to 69° C.
Elemental Analysis: C26 H29 N2 O3 P Cal. C: 69.63; H: 6.52; N:6.25; Found C: 69.66; H: 6.60; N: 6.61.
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR31##
______________________________________
(a) 1.32 b,
(9H,J = 6.6Hz)
(b) 1.49 d,
(c) 3.23 (4H, b)
(d) 5.15 (1H, q, J = 6.6Hz)
(e) 7.11 (15H, m)
______________________________________
1.10 g of enamine as prepared by the process as described in Example 5 and 1.65 g of DPPA were dissolved in 15 ml of ethyl acetate. The mixture was stirred for 1 hour at room temperature and 15 minutes at 55° C. and then refluxed for 3 hours. The reaction mixture was subjected to the work up as described in Example 12 to obtain 1.54 g of the desired amidine (yield: 63%).
The crude product was recrystalized from ethyl acetate-hexane to obtain colorless prisms having melting point of 71° to 73.5° C.
Elemental Analysis: C25 H27 N2 O4 P Cal. C: 66.65; H: 6.04; N: 6.22. Found C: 66.79; H: 6.12; N: 6.30.
NMR spectrum: δ ppm, CCl4 ##STR33##
1.22 g of enamine prepared by the process as described in Example 7 and 1.65 g of DPPA were dissolved in 15 ml of tetrahydrofuran. The mixture was stirred for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. The reaction mixture was subjected to the work up as described in Example 12 to obtain 1.87 g of the desired amidine as viscous oil (yield: 76%).
Elemental Analysis: C29 H35 N2 O3 P Cal. C: 71.00; H: 7.19; N: 5.71; Found C: 71.01; H: 7.20; N: 5.76.
IR spectrum: max cap cm-1
1565, 1493, 1246, 1222, 1203 and 920
NMR spectrum δ ppm, CCl4
______________________________________ ##STR35##
______________________________________ (a) 0.90 (6H, d, J = 6Hz) (b) 1.43 (3H, d, J = 7.2Hz) (c) 1.7 (5H, m) (d) 2.43 (2H, d, J = 7.2Hz) (e) 2.8 (4H, b) (f) 4.26 (1H, q, J = 7.2Hz) (g) 7.05 (4H, s) ______________________________________
0.95 g of 4-isobutylpropiophenone prepared by the process as described in Example 7, 1.07 g of pyrrolidine and 0.07 g of boron trifluoride etherate were dissolved in 60 ml of benzene and reacted as described in Example 7. The reaction mixture was subjected to a distillation under a reduced pressure to remove the solvent and then 15 ml of tetrahydrofuran and 1.65 g of DPPA were added. The mixture was stirred for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. The resulting reaction mixture was subjected to the work up as described in Example 12 to obtain 1.83 g of the desired amidine (yield: 75%).
Physical properties of the product were the same with those of the compound obtained by the process as described in Example 17.
A process similar to that as described in Example 18 excepting that the reaction was carried out under argon atmosphere was carried out to obtain 1.91 g of the desired amidine (yield: 78%). The product had physical properties as described in Example 17.
1.07 g of enamine prepared by the process as described in Example 10 and 1.32 g of DPPA were dissolved in 12 ml of tetrahydrofuran. The mixture was stirred under argon atmosphere for 1 hour at room temperature, 2 hours at 40° C. and 1 hour at 50° C. Thereafter, the resulting reaction mixture was subjected to the work up as described in Example 12 to obtain 1.33 g of the desired amidine (yield: 65%).
The crude product was recrystalized from ethyl acetate-hexane to obtain colorless needles having melting point of 102.5° to 105° C.
Elemental Analysis: C30 H31 N2 O3 P Cal. C: 70.02; H: 6.07; N: 5.45; Found C: 70.18; H: 6.28; N: 5.52.
NMR spectrum: δ ppm, CDCl3
______________________________________ ##STR38##
______________________________________ (a) 1.57-1.68 (7H, d and b, J = 7Hz) (b) 3.7-2.5 (4H, b) (c) 3.86 (3H, s) (d) 4.92 (1H, q, J = 7Hz) (e) 7.67-7.02 (16H, m) ______________________________________
1.07 g of the starting ketone, 1.07 g of pyrrolidine and 0.07 g of boron trifluoride etherate were treated and reacted as described in Example 10. The reaction mixture was subjected to a distillation under a reduced pressure to remove the solvent and then under argon atmosphere, 15 ml of tetrahydrofuran and 1.65 g of DPPA were added. The mixture was stirred for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. Thereafter, the resulting reaction mixture was subjected to the work up as described in Example 12 to obtain 2.10 g of the desired amidine (yield from the starting ketone: 82%).
Physical properties of the product were the same with those of the compound obtained by the process as described in Example 20.
601 mg of the starting ketone, 640 mg of pyrrolidine and 40 mg of boron trifluoride etherate were dissolved in 30 ml of toluene. The mixture was refluxed for 42 hours under argon atmosphere and using a Cope water separator and molecular sieve 4A as the dehydrating agent. The reaction mixture was subjected to a distillation under a reduced pressure to remove the solvent and 9 ml of tetrahydrofuran and 990 mg of DPPA were added. The mixture was stirred under argon atmosphere for 1 hour at room temperature, 1 hour at 40° C. and then refluxed for 2 hours. The resulting reaction mixture was subjected to the work up as described in Example 12 to obtain 1.11 g of desired amidine (yield from the starting ketone: 71%).
IR spectrum: νmax KBr cm-1
1560, 1482, 1241, 1218, 1195 and 916
NMR spectrum: δ ppm, CDCl3
______________________________________ ##STR41##
______________________________________
(a) Ca 1.6 (7H, d and b, J = 7Hz)
(b) 3.5-2.5 (4H, b)
(c) 4.88 (1H, q, J = 7Hz)
(d) 7.76 and 7.19
(17H, m)
______________________________________
0.71 g of enamine prepared by the process as described in Example 8 and 0.81 g of DPPA were dissolved in 7.5 ml of tetrahydrofuran. The mixture was stirred under argon atmosphere for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. To the reaction mixture, 60 ml of ethyl acetate-benzene (1:1 mixture) was added and washed subsequently with each 10 ml of 5% citric acid solution, water, saturated sodium chloride solution, saturated sodium bicarbonate solution, water and saturated sodium chloride solution, dried on anhydrous magnesium sulfate and then subjected to a distillation under a reduced pressure to remove the solvent. The residue was subjected to a silica-gel column chromatography with ethyl acetate-hexane (3:1 mixture) to obtain 0.93 g of the desired amidine (yield: 72%).
Elemental Analysis: C32 H31 N2 O4 P Cal. C: 71.36; H: 5.80; N: 5.20; Found C: 71.66; H: 6.10; N: 5.07.
IR spectrum: νmax KBr cm-1
1656 (C═O), 1559, 1484, 1241, 1196 and 918
NMR spectrum: δ ppm, CDCl3
______________________________________ ##STR43##
______________________________________ (a) 1.54 (7H, d, J = 7.2Hz) (b) 1.63 (7H, m, J = 7.2Hz) (c) 3.4 and 3 (4H, b) (d) 4.82 (1H, q, J = 7.2Hz) (e) 7.75-7.15 (19H, m) ______________________________________
531 mg of enamine prepared by the process as described in Example 9 and 0.62 g of DPPA were dissolved in 6 ml of tetrahydrofuran. The mixture was stirred under argon atmosphere for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. The reaction mixture was subjected to the work up as described in Example 12, excepting that the final reaction mixture was subjected to a silica-gel column chromatography with hexane-ethyl acetate (1:3 mixture), to obtain 674 mg of the desired amidine (yield: 68%). The crude product was recrystallized from ethyl acetate-hexane to obtain a colorless powder having melting point of 70°-73° C.
Elemental Analysis: C31 H30 N2 O3 FP Cal. C: 70.44; H: 5.72; N: 5.30; Found C: 70.34; H: 5.95; N: 5.08.
NMR spectrum: δ ppm, CDCl3
______________________________________ ##STR45##
______________________________________ (a) 1.54 (7H, d, J = 7.2Hz) (b) 1.72 (7H, m, J = 7.2Hz) (c) 3.5 and 3.1 (4H, b) (d) 4.81 (1H, q, J = 7.2Hz) (e) 7.2 (18H, m) ______________________________________
1.01 g of enamine prepared by the process as described in Example 2 and 1.65 g of DPPA were dissolved in 15 ml of tetrahydrofuran. The mixture was stirred for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. The reaction mixture was subjected to the work up as described in Example 12 to obtain 1.67 g of the desired amidine (yield: 74%). The crude product was recrystallized from ethyl acetate-hexane to obtain colorless needles having melting point of 83° to 85° C.
Elemental Analysis: C26 H29 N2 O3 P Cal. C: 69.63; H: 6.52; N: 6.25; Found C: 69.80; H: 6.49; N: 6.25.
NMR spectrum: δ ppm, CCl4
______________________________________ ##STR47##
______________________________________
(a) 0.94 (3H, t, J = 7Hz)
(b) 1.67
(6H, m)
(c) 1.91
(d) 3.05-3.72 (4H, b)
(e) 4.43 (1H, t)
(f) 7.17 (15H, m, J = 8Hz)
______________________________________
The process was similar to that as described in Example 25 except that the reaction was carried out under argon atmosphere to obtain 1.84 g of the desired amidine (yield: 82%). The product had physical properties as described in Example 25.
0.74 g of n-butyrophenone, 1.07 g of pyrrolidine and 0.07 g of boron trifluoride etherate were dissolved in 50 ml of benzene and subjected to the reaction as described in Example 2. The resulting reaction mixture was subjected to a distillation under a reduced pressure to remove the solvent and then under argon atmosphere 15 ml of tetrahydrofuran and 1.65 g of DPPA were added. The mixture was worked up as described in Example 25 to obtain 1.81 g of the desired amidine (yield from the raw material ketone: 81%). Physical properties of the product were same with those as described in Example 25.
805 mg of enamine prepared by the process as described in J. Org. Chem. Vol. 32, page 213 (1976) and 1.32 g of DPPA were dissolved in 12 ml of tetrahydrofuran. The mixture was stirred under argon atmosphere for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. The reaction mixture was subjected to the work up as described in Example 12 to obtain 1.25 g of the desired amidine (yield: 70%). The crude product was recrystallized from ethyl acetate-hexane to obtain colorless needles having melting point of 87° to 88.5° C.
Elemental Analysis: C26 H29 NO3 P Cal. C: 69.63; H:6.52; N:6.25; Found C:69.56; H: 6.57; N:6.31.
NMR spectrum: δ ppm, CCl4 ##STR50##
1.07 g of enamine prepared by the process as described in Example 3 and 1.65 g of DPPA were dissolved in 15 ml of tetrahydrofuran. The mixture was stirred under argon atmosphere for 1 hour at room temperature and 1 hour at 40° C. and then refluxed for 2 hours. The reaction mixture was subjected to the work up as described in Example 12 to obtain 1.84 g of the desired amidine (yield: 80%).
IR spectrum: νmax cap cm-1
1585, 1565, 1489, 1242, 1228, 1200 and 917
NMR spectrum: δ ppm, CCl4 ##STR52##
0.60 g of acetophenone, 1.17 g of pyrrolidine and 0.07 g of boron trifluoride etherate were dissolved in 30 ml of toluene and refluxed under argon atmosphere for 18 hours using a Cope water separator and molecular sieve 4A as the dehydrating agent. The reaction mixture was subjected to a distillation under a reduced pressure to remove the solvent and then 15 ml of tetrahydrofuran and 1.65 g of DPPA was added. The resulting mixture was allowed to react under argon atmosphere by stirring same for 24 hours at room temperature and then subjected to the work up as described in Example 12 to obtain 101 mg of the desired amidine (yield from the starting acetophenone: 5%).
IR spectrum: νmax cap cm-1
1567, 1486, 1246, 1220, 1198 and 920
NMR spectrum: δ ppm, CCl4 ##STR54##
0.751 g of 4-methoxyacetophenone, 1.07 g of pyrrolidine and 0.03 g of boron trifluoride etherate were dissolved in 30 ml of toluene and subjected to the reaction as described in Example 30. The reaction mixture was subjected to a distillation under a reduced pressure to remove the solvent, 1.65 g of DPPA and 15 ml of tetrahydrofuran were added and then subjected to the reaction as well as work up as described in Example 30 to obtain 245 mg of the desired amidine (yield from methoxyacetophenone: 11%).
Melting point: 72° to 75.5° C.
IR spectrum: νmax KBr cm-1
1562, 1484, 1239, 1196 and 917
NMR spectrum: δ ppm, CDCl3 ##STR56##
1.303 g of amidine prepared by the process as described in Example 12, 13 or 14 and 2.94 g of potassium hydroxide were dissolved in 40 ml of ethylene glycol and refluxed for 12 hours. The reaction mixture was diluted with 300 ml of water and pH of the solution was made about 9 by passing therein carbon dioxide gas and then washed with ethyl ether. After having acidified with hydrochloric acid, the aqueous phase was extracted with ethyl acetate and then an organic phase was washed by water and saturated sodium chloride solution, dried on magnesium bisulfate and distilled under a reduced pressure to remove the solvent and to obtain 408 g of the desired acid (yield 91%).
Boiling point: 103° to 105° C./3 mmHg
1.473 g of amidine prepared by the process as described in Example 17, 18 or 19 and 2.95 g of potassium hydroxide were dissolved in 35 ml of ethylene glycol and refluxed for 12 hours and then subjected to the work up as described in Example 32 to obtain 489 mg of the desired acid (yield: 79%). The crude product was recrystallized from petroleum benzene to obtain colorless needles having melting point of 74° to 75° C.
515 mg of amidine prepared by the process as described in Example 20 or 21 and 0.35 g of potassium hydroxide were dissolved in 10 ml of ethylene glycol and refluxed for 8 hours. The reaction mixture was subjected to the work up as described in Example 32 to obtain the desired acid (yield: 83%).
The crude product was purified by a silica-gel chromatography with chloroform-methanol-acetic acid (200:10:1) to obtain 157 mg of colorless needle crystals (yield: 71%).
Melting point: 151.5°-152.5° C.
825 mg of amidine prepared by the process as described in Example 22 and 1.57 g of potassium hydroxide were dissolved in 30 ml of ethylene glycol and refluxed for 7 hours. The reaction mixture was subjected to the work up as described in Example 32 to obtain 345 mg of the desired acid (yield: 92%). The crude product was recrystallized from ethyl acetate-hexane to obtain colorless needles having melting point of 141° to 142.5° C.
528 mg of amidine prepared by the process as described in Example 24 and 0.3 g of potassium hydroxide were dissolved in 10 ml of ethylene glycol and refluxed for 8 hours. The reaction mixture was subjected to the work up as described in Example 32 to obtain 73 mg of the desired acid (yield: 30%). The crude product was recrystallized from ethyl acetate-hexane to obtain colorless crystals having melting point of 113° to 114° C.
0.45 g of amidine prepared by the process as described in Example 25, 26 or 27 and 1.00 g of potassium hydroxide were dissolved in 20 ml of ethylene glycol and refluxed for 6 hours. The reaction mixture was poured into 200 ml of water and then to the resulting solution, carbon dioxide gas was bubbled to make pH to about 9. After having been washed 5 times with 50 ml of ethyl ether, the aqueous phase was acidified with conc. hydrochloric acid and extracted 4 times with 50 ml of ethyl acetate. The extracts were subsequently washed with water and saturated sodium chloride solution and then dried on magnesium sulfate. The residue obtained by distilled out the solvent under a reduced pressure was purified by chromatography to obtain 0.15 g of the desired acid (yield: 91%) having melting point of 42° to 43° C.
0.45 g of amidine prepared by the process as described in Example 28 and 1.00 g of potassium hydroxide were dissolved in 20 ml of ethylene glycol and refluxed for 6 hours. The reaction mixture was subjected to the work up as described in Example 37 to obtain 0.165 g of the desired acid having melting point of 75° to 77.5° C.
0.46 g of amidine prepared by the process as described in Example 29 and 1.00 g of potassium hydroxide were dissolved in 20 ml of ethylene glycol and refluxed for 6 hours. The reaction mixture was subjected to the work up as described in Example 37 to obtain 0.16 g of the desired acid (yield: 91%) having melting point of 34° C.
423 mg of amidine prepared by the process as described in Example 23 and 0.77 g of potassium hydroxide were dissolved in 15 ml of ethylene glycol and refluxed for 6 hours.
The reaction mixture was subjected to the work up as described in Example 37 to obtain 139 mg of the crude acid.
To the crude acid dissolved in 5.5 ml of acetone, Jones reagent (E. R. H. Jones J. Chem. Soc. 1953, 2548) was added until a blue-yellow solution turns to a red-yellow and then a small amount of isopropanol was added to turn the the solution color to colorless. The resulting acid solution was dissolved in 190 ml of chloroform, washed with water, dried on magnesium sulfate and distilled under a reduced pressure to remove the soluvent and obtain 123 mg of the desired acid as colorless viscous oil (yield: 62%).
IR spectrum: νmax cap cm-1
1730, 1705 (-COOH), 1655 ##STR66##
NMR spectrum: δ ppm, CDCl3
Claims (1)
1. An amidine compound represented by the formula
wherein R1 represents hydrogen or lower alkyl, R2 represents hydrogen, lower alkyl or allyl, R2 represents phenyl, lower alkyl substituted phenyl, lower alkoxy substituted phenyl, cyclohexenyl substituted phenyl, benzoyl substituted phenyl, methoxy substituted naphthyl, dibenzofuranyl, or halogen substituted biphenyl and R4 represents 1-piperidyl.
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP52-123594 | 1977-10-17 | ||
| JP12359477A JPS5459238A (en) | 1977-10-17 | 1977-10-17 | Novel method for producing carboxylic acid derivatives and intermediate thereof |
| JP53-023208 | 1978-03-01 | ||
| JP53-023207 | 1978-03-01 | ||
| JP2320878A JPS54117466A (en) | 1978-03-01 | 1978-03-01 | Novel enamine compound |
| JP2320778A JPS596319B2 (en) | 1978-03-01 | 1978-03-01 | Novel amidine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US4198510A true US4198510A (en) | 1980-04-15 |
Family
ID=27284166
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US05/922,524 Expired - Lifetime US4198510A (en) | 1977-10-17 | 1978-07-07 | Piperidenylmethylidene phosphonylamidines |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US4198510A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4762948A (en) * | 1987-01-21 | 1988-08-09 | Sumitomo Chemical Company, Limited | Process for preparing optically active arylacetic acid derivative |
| US4876366A (en) * | 1986-05-05 | 1989-10-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US4937263A (en) * | 1986-05-05 | 1990-06-26 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3949022A (en) * | 1972-04-06 | 1976-04-06 | Bayer Aktiengesellschaft | N-[N',N'-disubstituted-aminomethylidene]-(thiono)thiol-phosphoric acid ester imides |
| US3975522A (en) * | 1971-12-17 | 1976-08-17 | Ciba-Geigy Corporation | Control of insects and acarids with N-phosphinylamidines |
-
1978
- 1978-07-07 US US05/922,524 patent/US4198510A/en not_active Expired - Lifetime
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3975522A (en) * | 1971-12-17 | 1976-08-17 | Ciba-Geigy Corporation | Control of insects and acarids with N-phosphinylamidines |
| US3949022A (en) * | 1972-04-06 | 1976-04-06 | Bayer Aktiengesellschaft | N-[N',N'-disubstituted-aminomethylidene]-(thiono)thiol-phosphoric acid ester imides |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4876366A (en) * | 1986-05-05 | 1989-10-24 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US4937263A (en) * | 1986-05-05 | 1990-06-26 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| US4762948A (en) * | 1987-01-21 | 1988-08-09 | Sumitomo Chemical Company, Limited | Process for preparing optically active arylacetic acid derivative |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Imuta et al. | Product stereospecificity in the microbial reduction of. alpha.-haloaryl ketones | |
| EP0022162A1 (en) | Process for producing disubstituted 4-hydroxycyclopentenones; monosubstituted cyclopentendiones and 4-hydroxycyclopentenones | |
| Tatone et al. | Optically active heteroaromatic compounds. VII. Synthesis of the three optically active sec-butylpyridines | |
| DD291749A5 (en) | METHOD FOR PRODUCING BENZOCYCLOALKENYLDIHYDROXYALKANSAEUREDERIVATES | |
| Hoffman et al. | 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3, 5-dihydroxy-6-heptenoic acids and their lactone derivatives | |
| US4198510A (en) | Piperidenylmethylidene phosphonylamidines | |
| US4634768A (en) | Halo-containing 3-methylflavone-8-carboxylic acid derivatives | |
| US4593037A (en) | 1,3-disubstituted piperidine compounds as neuroleptic agents | |
| US4954659A (en) | 1,4-bis (dihydroxyphenyl) butane and analogs | |
| US4623728A (en) | Intermediates for 1,3-disubstituted piperidine compounds as neuroleptic agents | |
| Paul et al. | Synthesis of oxathiane and morpholine from acyclic precursors: a modified Mitsunobu reaction | |
| EP0397042B1 (en) | Process for the preparation of isoquinoline derivatives | |
| CS202044B2 (en) | Method of preparation of 2-arylpropione acids | |
| US3453283A (en) | Novel 6-substituted-1-(piperidyl-alkyl)-1,2,3,4-tetrahydronaphthalenes | |
| HU220971B1 (en) | Process for producing 0-(3-amino-2-hidroxy-propyl)-hidroxim acid halogenids | |
| CROMWELL et al. | Endocyclic α, β-Unsaturated Ketones. V. 1 Synthesis and Reaction of 3-Bromo-1, 1-dimethyl-2-keto-1, 2-dihydronaphthalene with Morpholine | |
| US4876345A (en) | Indene compounds | |
| JPH0386873A (en) | Manufacture of 1, 3-dioxoran- ketone | |
| US4918190A (en) | Crystalline complex compounds of propargyl alcohols and tertiary diamines, and process of separation and purification of propargyl alcohols using the same | |
| US3173917A (en) | Method of preparing substituted phenylpiperazines | |
| EP0492401A1 (en) | Asymmetric hydrogenation | |
| JP2573818B2 (en) | Crystalline complex compounds of propargyl alcohols and tertiary diamines | |
| EP0003316B1 (en) | Stereospecific process for the preparation of 2-oxiranyl-1,4-benzodioxanes | |
| MORIMOTO et al. | Decarboxylation Reactions. IX. Reaction of Enamines with Trichloroacetic Anhydride | |
| US4169858A (en) | Process for preparing a ketone |